Cancer drug developer, Gates Foundation plot next attack on malaria

·3 min read
Cancer drug developer, Gates Foundation plot next attack on malaria

With technology licensed from Stanford, the partners hope to land a preventive drug into clinical trials against malaria by early 2023.